Clinical Trial Update: Effect of Bevacizumab on Radiation-induced Brain Necrosis in Patients With Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial assessing bevacizumab for radiation-induced brain necrosis in patients with nasopharyngeal carcinoma has completed recruitment with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Necrosis
• Nasopharyngeal Carcinoma

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Nasopharyngeal Carcinoma, Adverse Effect of Radiation Therapy | Phase 2 | Status: COMPLETED | Results posted: 2018-11-26